Journal Article

Clozapine (generic versus branded) for people with schizophrenia

Cochrane Database of Systematic Reviews (2019) 2019(1)
DOI: 10.1002/14651858.CD013248
2Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy, costs and safety of generic clozapine compared with branded clozapine for people with schizophrenia.

Cite

CITATION STYLE

APA

Turkmani, K., Marwa, M. E., Ahmad, B., Ahmad, T., Alrstom, A., & Essali, A. (2019). Clozapine (generic versus branded) for people with schizophrenia. Cochrane Database of Systematic Reviews, 2019(1). https://doi.org/10.1002/14651858.CD013248

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free